Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 09, 2023
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.
Journal: International journal of cancer
Published: May 19, 2021
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
Journal: Breast cancer research and treatment
Published: March 22, 2021
Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors.
Journal: Nature cancer
Published: August 31, 2020
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer.
Journal: Breast cancer research and treatment
Published: July 31, 2020
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
Journal: Breast cancer research and treatment
Published: May 21, 2020
Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 10, 2020
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: November 12, 2019
Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.
Journal: American journal of clinical pathology
Published: October 16, 2019
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
Journal: Fertility and sterility
Published: August 21, 2019
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 05, 2019
Correction: 18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2019
Last Updated: 09/26/2026